Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator

Journal of Stroke and Cerebrovascular Diseases

Volumn 25, Issue 11, 2016, Pages 2569-2574

  Fredwall, Megan ^a   Sternberg, Shannon ^b   Blackhurst, Dawn ^b   Lee, Andrew ^a   Leacock, Rodney ^b   Nathaniel, Thomas I ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE GREENVILLE   (United States)

^b GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

contraindication; Gender; ischemic stroke; recombinant tissue type plasminogen activator (r tPA)

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN SURGERY; BRAIN TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HEAD INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; PARTIAL THROMBOPLASTIN TIME; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SEIZURE; SEX DIFFERENCE; SPINE SURGERY; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; ADVERSE EFFECTS; DISABILITY; FIBRINOLYTIC THERAPY; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; REGISTER; RISK ASSESSMENT; RISK FACTOR; SCINTIGRAPHY; SOUTH CAROLINA; STROKE; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; FEMALE; FIBRINOLYTIC AGENTS; HEALTHCARE DISPARITIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT SELECTION; PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROCESS ASSESSMENT (HEALTH CARE); RECOMBINANT PROTEINS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SOUTH CAROLINA; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84994759966     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2016.06.012     Document Type: Article

References (50)

1. 1 Johansen, H.L., Wielgosz, A.T., Nguyen, K., et al. Incidence, comorbidity, case fatality and readmission of hospitalized stroke patients in Canada. Can J Cardiol 22 (2006), 65–71.
2. 2 Holroyd-Leduc, J.M., Kapral, M.K., Austin, P.C., et al. Sex differences and similarities in the management and outcome of stroke patients. Stroke 31 (2000), 1833–1837.
3. 3 Fukuda, M., Kanda, T., Kamide, N., et al. Gender differences in long-term functional outcome after first-ever ischemic stroke. Intern Med 48 (2009), 967–973.
4. 4 Irie, F., Kamouchi, M., Hata, J., et al. Sex differences in short-term outcomes after acute ischemic stroke the Fukuoka Stroke Registry. Stroke 46 (2015), 471–476.
5. 5 Kapral, M.K., Devon, J., Winter, A.L., et al. Gender differences in stroke care decision-making. Med Care 44 (2006), 70–80.
6. 6 Lasek-Bal, A., Puz, P., Kazibutowska, Z., Efficacy and safety assessment of alteplase in the treatment of stroke—gender differences. Neurol Res 36 (2014), 851–856.
7. 7 Oh, S., Yu, K.H., Roh, J.K., et al. Gender differences in the mortality and outcome of stroke patients in Korea. Cerebrovasc Dis 28 (2009), 427–434.
8. 8 Kapral, M.K., Fang, J., Hill, M.D., et al., Investigators of the Registry of the Canadian Stroke Network. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 36 (2005), 809–814.
9. 9 Maeda, K., Toyoda, K., Minematsu, K., et al. Effects of sex difference on clinical features of acute ischemic stroke in Japan. J Stroke Cerebrovasc Dis 22 (2013), 1070–1075.
10. 10 Ovbiagele, B., Nguyen-Huynh, M.N., Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurother 8 (2011), 319–329.
11. 11 Park, S.J., Shin, S.D., Ro, Y.S., et al. Gender differences in emergency stroke care and hospital outcome in acute ischemic stroke: a multicenter observational study. Am J Emerg Med 31 (2013), 178–184.
12. 12 Towfighi, A., Markovic, D., Ovbiagele, B., Sex differences in revascularization interventions after acute ischemic stroke. J Stroke Cerebrovasc Dis 22 (2013), E347–E353.
13. 13 Yesilot, N., Koyuncu, B.A., Coban, O., et al. Gender differences in acute stroke: Istanbul Medical School Stroke Registry. Neurol India 59 (2011), 174–179.
14. 14 Kent, D.M., Price, L.L., Ringleb, P., et al. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 36 (2005), 62–65.
15. 15 Kim, J.S., Lee, K.B., Roh, H., et al. Gender differences in the functional recovery after acute stroke. J Clin Neurol 6 (2010), 183–188.
16. 16 Reid, J.M., Dai, D.W., Gubitz, G.J., et al. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke 39 (2008), 1090–1095.
17. 17 Madsen, T.E., Khoury, J.C., Alwell, K.A., et al. Analysis of tissue plasminogen activator eligibility by sex in the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke 46 (2015), 717–721.
18. 18 Loikas, D., Wettermark, B., von Euler, M., et al. Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden. BMJ Open, 3, 2013.
19. 19 Arboix, A., Cartanya, A., Lowak, M., et al. Gender differences and woman-specific trends in acute stroke: results from a hospital-based registry (1986-2009). Clin Neurol Neurosurg 127 (2014), 19–24.
20. 20 Martínez-Sánchez, P., Fuentes, B., Fernandez-Dominguez, J., et al. Young women have poorer outcomes than men after stroke. Cerebrovasc Dis 31 (2011), 455–463.
21. 21 Falcone, G., Chong, J.Y., Gender differences in stroke among older adults. Geriatr Aging 10 (2007), 497–500.
22. 22 Meseguer, E., Mazighi, M., Labreuche, J., et al. Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender a clinical registry study and systematic review. Stroke 40 (2009), 2104–2110.
23. 23 Saver, J.L., Fonarow, G.C., Smith, E.E., et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 309 (2013), 2480–2488.
24. 24 Savitz, S.I., Schlaug, G., Caplan, L., et al. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 36 (2005), 1447–1451.
25. 25 Di Legge, S., Saposnik, G., Nilanont, Y., et al. Neglecting the difference—does right or left matter in stroke outcome after thrombolysis?. Stroke 37 (2006), 2066–2069.
26. 26 Appelros, P., Stegmayr, B., Terent, A., A review on sex differences in stroke treatment and outcome. Acta Neurol Scand 121 (2010), 359–369.
27. 27 De Silva, D.A., Ebinger, M., Davis, S.M., Gender issues in acute stroke thrombolysis. J Clin Neurosci 16 (2009), 501–504.
28. 28 Reeves, M.J., Fonarow, G.C., Zhao, X., et al. Quality of care in women with ischemic stroke in the GWTG program. Stroke 40 (2009), 1127–1133.
29. 29 Turtzo, L.C., McCullough, L.D., Sex differences in stroke. Cerebrovasc Dis 26 (2008), 462–474.
30. 30 Reeves, M., Bhatt, A., Jajou, P., et al. Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke a meta-analysis. Stroke 40 (2009), 1743–1749.
31. 31 Bushnell, C., McCullough, L.D., Awad, I.A., et al. Guidelines for the prevention of stroke in women a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45 (2014), 1545–1588.
32. 32 Santalucia, P., Pezzella, F.R., Sessa, M., et al. Sex differences in clinical presentation, severity and outcome of stroke: results from a hospital-based registry. Eur J Intern Med 24 (2013), 167–171.
33. 33 Silva, G.S., Lima, F.O., Camargo, E.C.S., et al. Gender differences in outcomes after ischemic stroke: role of ischemic lesion volume and intracranial large-artery occlusion. Cerebrovasc Dis 30 (2010), 470–475.
34. 34 Wang, Z., Li, J.J., Wang, C.X., et al. Gender differences in 1-year clinical characteristics and outcomes after stroke: results from the China national stroke registry. PLoS ONE, 8, 2013.
35. 35 Schwamm, L.H., Ali, S.F., Reeves, M.J., et al. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get with the Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes 6 (2013), 543–549.
36. 36 Ramnanan, C.J., Allan, M.E., Groom, A.G., et al. Regulation of global protein translation and protein degradation in aerobic dormancy. Mol Cell Biochem 323 (2009), 9–20.
37. 37 Foerch, C., Misselwitz, B., Humpich, M., et al. Sex disparity in the access of elderly patients to acute stroke care. Stroke 38 (2007), 2123–2126.
38. 38 Rosamond, W., Flegal, K., Friday, G., et al. Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007), e69–e171.
39. 39 Haley, K.E., Greenberg, S.M., Gurol, M.E., Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?. Curr Cardiol Rep, 15, 2013.
40. 40 Chapman, S.N., Mehndiratta, P., Johansen, M.C., et al. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag 10 (2014), 75–87.
41. 41 Khatri, P., Conaway, M.R., Johnston, K.C., et al. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke 43 (2012), 560–562.
42. 42 Tanne, D., Gorman, M.J., Bates, V.E., et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older—the tPA stroke survey experience. Stroke 31 (2000), 370–375.
43. 43 Mishra, N.K., Ahmed, N., Andersen, G., et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. Br Med J, 341, 2010.
44. 44 Gomez-Choco, M., Obach, V., Urra, X., et al. The response to IV rt-PA in very old stroke patients. Eur J Neurol 15 (2008), 253–256.
45. 45 Jauch, E.C., Saver, J.L., Adams, H.P., et al. Guidelines for the early management of patients with acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44 (2013), 870–947.
46. 46 Powers, W.J., Derdeyn, C.P., Biller, J., et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46 (2015), 3020–3035.
47. 47 Boulouis, G., Dumont, F., Cordonnier, C., et al. Intravenous thrombolysis for acute cerebral ischaemia in old stroke patients ≥ 80 years of age. J Neurol 259 (2012), 1461–1467.
48. 48 Matsuo, R., Kamouchi, M., Fukuda, H., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry. PLoS ONE, 9, 2014.
49. 49 Sarikaya, H., Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients. Drugs Aging 30 (2013), 227–234.
50. 50 Howard, G., Goff, D.C., Population shifts and the future of stroke: forecasts of the future burden of stroke. Ann N Y Acad Sci 1268 (2012), 14–20.